Johnson & Johnson (JNJ) Research & Development (2009 - 2026)

Johnson & Johnson has disclosed Research & Development across 18 years of filings, most recently posting $3.7 billion for Q2 2026.

• In Q2 2026, Research & Development rose 3.9% year-over-year to $3.7 billion; the TTM figure through Jun 2026 stood at $15.1 billion (down 11.11% YoY), while the FY2025 annual figure was $14.7 billion, down 14.9% from the prior year.
• Research & Development came in at $3.7 billion for Q2 2026 at Johnson & Johnson, up from $3.5 billion in the prior quarter.
• In the past five years, Research & Development ranged from a high of $6.2 billion in Q1 2022 to a low of $3.2 billion in Q1 2025.
• Average Research & Development over 5 years is $4.0 billion, with a median of $3.7 billion recorded in 2026.
• Year-over-year, Research & Development tumbled 32.67% in 2023 and jumped 43.66% in 2024.
• Over 5 years, Research & Development stood at $3.5 billion in 2022, then rose by 28.55% to $4.5 billion in 2023, then rose by 18.26% to $5.3 billion in 2024, then declined by 19.74% to $4.3 billion in 2025, then decreased by 14.09% to $3.7 billion in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $3.7 billion in Q2 2026, $3.5 billion in Q1 2026, and $4.3 billion in Q4 2025.